Oracle Stock Is Down 58% From Its Peak -- but Revenue Is Still Growing by Double Digits. Time to Buy?

Oracle reported fiscal 2026 revenue up 17% to ~$67.4B and net income up 37% to ~$17B, alongside a 93% jump in Oracle Cloud Infrastructure to ~$5.8B and Q4 revenue up 21% YoY to $19.2B. The stock is down ~58% from its prior record (~$345.72) as investors focus on AI data-center build-out costs: capex of ~$55.7B and ~$43B in new debt driving deeply negative free cash flow. While the ~$638B backlog (up 363% YoY) signals strong contracted AI demand, concentration in a handful of giant deals and leverage raise downside risk if returns on spending disappoint.

Analysis

Oracle is no longer being valued like a software compounder; the market is pricing it like a capital-intensive utility with execution and financing risk. That shifts the real winners toward the upstream enablers of AI infrastructure — especially GPU and networking vendors — because the economics of the build-out are being pushed into their supply chain while Oracle’s equity absorbs the leverage and depreciation burden. In the near term, any relief rally in the shares can be fragile because sentiment is being driven by balance-sheet optics, not by revenue growth.

The key second-order issue is that a very concentrated customer base can keep headline growth high right up until one or two spenders pause, at which point the long-dated backlog narrative loses credibility fast. Over 1-3 months, the catalyst is not another big contract announcement; it is whether Oracle can show improving free-cash-flow trajectory or at least slower capex intensity. If credit spreads widen or refinancing costs rise, the equity multiple can compress further even if bookings stay strong.

Contrarianly, the market may be overstating how quickly the downside matures: if AI compute demand remains tight, Oracle’s backlog effectively converts into a financed growth option, and today’s discount can prove too deep. But that bull case depends on continued customer prepayments and on Oracle avoiding a forced slowdown in capacity adds. The thesis is falsified if capex stays elevated while revenue growth decelerates, or if management leans on more debt without a visible FCF inflection over the next two quarters.

Key Decisions for Investors

• Relative-value: long NVDA / short ORCL for 3-6 months. The trade expresses the view that AI capex still accrues more reliably to the upstream chip supplier than to the levered infrastructure operator. Stop if ORCL shows a credible free-cash-flow inflection or if NVDA data-center demand commentary rolls over.
• Do not chase ORCL here; wait for evidence that capex is normalizing or that operating cash flow is catching up. Best entry is only after one earnings print confirms lower capex intensity or stronger cash conversion.
• Tactical hedge: buy ORCL puts on a 10-15% relief rally rather than into weakness. That improves asymmetry because the stock can bounce on backlog headlines while the fundamental risk remains balance-sheet compression over the next 1-2 quarters.
• Watch ORCL credit spreads and new debt issuance as the real leading indicator. If spreads widen materially while equity is flat-to-up, that is a stronger short signal than the common stock alone.
• If you want AI exposure with less financing risk, prefer a basket tilt toward NVDA / AMAT / AVGO over ORCL for the next 6-12 months; the market is rewarding vendors with pricing power and penalizing the company funding the build.